vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and PROSPERITY BANCSHARES INC (PB). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $367.6M, roughly 1.7× PROSPERITY BANCSHARES INC). PROSPERITY BANCSHARES INC runs the higher net margin — 31.6% vs 3.3%, a 28.3% gap on every dollar of revenue. Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 19.2%).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
HIMS vs PB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $617.8M | $367.6M |
| Net Profit | $20.6M | $116.3M |
| Gross Margin | 71.9% | — |
| Operating Margin | 1.5% | — |
| Net Margin | 3.3% | 31.6% |
| Revenue YoY | 28.4% | — |
| Net Profit YoY | -20.8% | -10.7% |
| EPS (diluted) | $0.08 | $1.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $367.6M | ||
| Q4 25 | $617.8M | $275.0M | ||
| Q3 25 | $599.0M | $273.4M | ||
| Q2 25 | $544.8M | $267.7M | ||
| Q1 25 | $586.0M | $265.4M | ||
| Q4 24 | $481.1M | $267.8M | ||
| Q3 24 | $401.6M | $261.7M | ||
| Q2 24 | $315.6M | $258.8M |
| Q1 26 | — | $116.3M | ||
| Q4 25 | $20.6M | $139.9M | ||
| Q3 25 | $15.8M | $137.6M | ||
| Q2 25 | $42.5M | $135.2M | ||
| Q1 25 | $49.5M | $130.2M | ||
| Q4 24 | $26.0M | $130.1M | ||
| Q3 24 | $75.6M | $127.3M | ||
| Q2 24 | $13.3M | $111.6M |
| Q1 26 | — | — | ||
| Q4 25 | 71.9% | — | ||
| Q3 25 | 73.8% | — | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 73.5% | — | ||
| Q4 24 | 76.8% | — | ||
| Q3 24 | 79.2% | — | ||
| Q2 24 | 81.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.5% | 65.1% | ||
| Q3 25 | 2.0% | 64.4% | ||
| Q2 25 | 4.9% | 64.3% | ||
| Q1 25 | 9.9% | 62.7% | ||
| Q4 24 | 3.9% | 62.0% | ||
| Q3 24 | 5.6% | 62.1% | ||
| Q2 24 | 3.5% | 55.2% |
| Q1 26 | — | 31.6% | ||
| Q4 25 | 3.3% | 50.9% | ||
| Q3 25 | 2.6% | 50.3% | ||
| Q2 25 | 7.8% | 50.5% | ||
| Q1 25 | 8.4% | 49.1% | ||
| Q4 24 | 5.4% | 48.6% | ||
| Q3 24 | 18.8% | 48.6% | ||
| Q2 24 | 4.2% | 43.1% |
| Q1 26 | — | $1.16 | ||
| Q4 25 | $0.08 | $1.48 | ||
| Q3 25 | $0.06 | $1.45 | ||
| Q2 25 | $0.17 | $1.42 | ||
| Q1 25 | $0.20 | $1.37 | ||
| Q4 24 | $0.10 | $1.36 | ||
| Q3 24 | $0.32 | $1.34 | ||
| Q2 24 | $0.06 | $1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $540.9M | $8.2B |
| Total Assets | $2.2B | $43.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $228.6M | — | ||
| Q3 25 | $345.8M | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $273.7M | — | ||
| Q4 24 | $220.6M | — | ||
| Q3 24 | $165.5M | — | ||
| Q2 24 | $129.3M | — |
| Q1 26 | — | $8.2B | ||
| Q4 25 | $540.9M | $7.6B | ||
| Q3 25 | $581.0M | $7.7B | ||
| Q2 25 | $562.7M | $7.6B | ||
| Q1 25 | $549.3M | $7.5B | ||
| Q4 24 | $476.7M | $7.4B | ||
| Q3 24 | $440.1M | $7.4B | ||
| Q2 24 | $362.0M | $7.3B |
| Q1 26 | — | $43.6B | ||
| Q4 25 | $2.2B | $38.5B | ||
| Q3 25 | $2.2B | $38.3B | ||
| Q2 25 | $1.9B | $38.4B | ||
| Q1 25 | $891.7M | $38.8B | ||
| Q4 24 | $707.5M | $39.6B | ||
| Q3 24 | $602.3M | $40.1B | ||
| Q2 24 | $480.5M | $39.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $61.3M | — |
| Free Cash FlowOCF − Capex | $-2.5M | — |
| FCF MarginFCF / Revenue | -0.4% | — |
| Capex IntensityCapex / Revenue | 10.3% | — |
| Cash ConversionOCF / Net Profit | 2.98× | — |
| TTM Free Cash FlowTrailing 4 quarters | $57.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $61.3M | $78.3M | ||
| Q3 25 | $148.7M | $194.8M | ||
| Q2 25 | $-19.1M | $98.2M | ||
| Q1 25 | $109.1M | $178.2M | ||
| Q4 24 | $86.4M | $-205.8M | ||
| Q3 24 | $85.3M | $274.6M | ||
| Q2 24 | $53.6M | $216.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-2.5M | $68.5M | ||
| Q3 25 | $79.3M | $185.7M | ||
| Q2 25 | $-69.5M | $91.8M | ||
| Q1 25 | $50.1M | $171.1M | ||
| Q4 24 | $59.5M | $-210.7M | ||
| Q3 24 | $79.4M | $270.2M | ||
| Q2 24 | $47.6M | $211.8M |
| Q1 26 | — | — | ||
| Q4 25 | -0.4% | 24.9% | ||
| Q3 25 | 13.2% | 67.9% | ||
| Q2 25 | -12.8% | 34.3% | ||
| Q1 25 | 8.5% | 64.5% | ||
| Q4 24 | 12.4% | -78.7% | ||
| Q3 24 | 19.8% | 103.3% | ||
| Q2 24 | 15.1% | 81.8% |
| Q1 26 | — | — | ||
| Q4 25 | 10.3% | 3.6% | ||
| Q3 25 | 11.6% | 3.3% | ||
| Q2 25 | 9.3% | 2.4% | ||
| Q1 25 | 10.1% | 2.7% | ||
| Q4 24 | 5.6% | 1.8% | ||
| Q3 24 | 1.5% | 1.7% | ||
| Q2 24 | 1.9% | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 2.98× | 0.56× | ||
| Q3 25 | 9.43× | 1.42× | ||
| Q2 25 | -0.45× | 0.73× | ||
| Q1 25 | 2.20× | 1.37× | ||
| Q4 24 | 3.32× | -1.58× | ||
| Q3 24 | 1.13× | 2.16× | ||
| Q2 24 | 4.03× | 1.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIMS
Segment breakdown not available.
PB
| Net Interest Income | $321.1M | 87% |
| Noninterest Income | $46.5M | 13% |